GVI team forces with Biolution to Empower Companies Entering the DACH Region with Funding and Market Access
Biolution, a leading consultancy specialising in grant support and strategic advisory for life sciences and biotech, has joined forces with Gold Ventures Investment (GVI), an international innovation and investment platform.
This collaboration is set to provide companies expanding into the DACH region (Germany, Austria, and Switzerland) with a powerful combination of funding expertise and market access strategies, enabling them to successfully establish themselves in the Austrian biotope, fostering innovative companies and gaining access to the European market.
Austria offers unparalleled funding opportunities for research-intensive companies through national programmes and European opportunities such as Horizon Europe, and EIC Accelerator.
However, accessing these resources requires in-depth knowledge of the application landscape and strategic planning to develop competitive proposals.
GVI selected Biolution for its proven track record in securing the most competitive grants with a unique hands-on approach rooted in its scientific expertise to provide tailored guidance to help international R&D businesses navigate complex funding processes.
This will enable GVI to leverage its extensive investment network and acceleration programmes to help companies scale their operations, secure the right partners and develop their European entry market strategy.
By collaborating with Biolution as life science experts, GVI seeks to increase the success rate of start-ups and mature technology companies. This partnership is designed to help these ventures scale effectively and emerge as strong players in the global market.